Mergers & Antitrust Law News

Sanofi Wins Dismissal of Antitrust Claims on Diabetes Drug

Jan. 11, 2018, 9:20 PM

Sanofi-Aventis U.S. LLC had reason to assert a patent on two insulin drugs against a potential competing product, a Massachusetts federal court said in dismissing a lawsuit claiming the drugmaker monopolized the market.

Lantus is a diabetes treatment sold in vials or an injector pen. The plaintiffs contended that Sanofi’s legal patent monopoly on the drug ended in February 2015. They said Sanofi illegally extended its monopoly by listing six other patents in the “Orange Book” of FDA-approved drugs and suing Eli Lilly & Co. even though those patents that didn’t really apply to the product.

Magistrate Judge Judith G....

To read the full article log in. To learn more about a subscription click here.